LKFT

33.3600.09%
JV

Jane Veronica Griffiths

Non-Executive Independent Director

Dr. Jane Veronica Griffiths serves as Non-Executive Independent Director of Lakefront Biotherapeutics NV (formerly known as Galapagos NV) since July 28, 2025. Dr. Griffiths serves as Member of Healthcare Advisory Board at Inflexion Private Equity Partners LLP since joining the firm in December 2021. She is working at Johnson & Johnson Impact Ventures. She was Chair of Redx Pharma Ltd since December 01, 2021 until 2025. She had been Independent Non-Executive Director at BAE Systems plc since April 1, 2020 until 2025. Dr. Griffiths served as Global Head at Actelion since, May, 2017 until December 2019. Dr. Griffiths served as Group Chairman of Janssen EMEA at Johnson & Johnson. Dr. Griffiths joined Johnson & Johnson in 1982 and had undertaken a series of roles including international and affiliate strategic marketing, sales management, product management, general management and clinical research until her retirement in 2019. She was Chair of the Johnson & Johnson Corporate Citizenship Trust in EMEA. She was an Independent Non-Executive Director of Johnson Matthey Plc since January 1, 2017 until December 31, 2024. She is a member of the board of directors of TB Alliance. She was Chair of the European Federation of Pharmaceutical Industries and Associations. She served as a member of the Corporate Advisory Board of the UK Government backed ‘Your Life’ campaign which aims to encourage more young people to study STEM subjects. She is Director of The White Ribbon Alliance, Voza Developments Kinnerton Limited and Voza Developments Passmore Limited. Dr. Griffiths has a Ph.D in Plant Biochemistry/Genetics. She holds BSc in Agricultural Botany from University of Wales, Aberystwyth.

Positions